Post-traumatic inflammation following spinal cord injury

Spinal Cord

Volumn 41, Issue 7, 2003, Pages 369-378

  Hausmann, O N ^a,b  

^a University Hospital Basel   (Czech Republic)

^b Klinik St Anna   (Switzerland)

Author keywords

Astrocytes; Inflammation; Macrophages; Microglia; Spinal cord injury

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

APOPTOSIS; ASTROCYTE; CELL ACTIVATION; HUMAN; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROGLIA; MITOCHONDRION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

ANIMALS; CALCIUM; CELL DEATH; FREE RADICALS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; HUMANS; INFLAMMATION; MITOCHONDRIA; NEUROGLIA; NEURONS; NEUROTOXINS; NITRIC OXIDE; SPINAL CORD INJURIES; WALLERIAN DEGENERATION;

EID: 0038340422     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3101483     Document Type: Review

References (114)

1. Acarin L et al. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur J Neurosci 2000; 12: 3505-3520.
2. Bartholdi D, Schwab ME. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur J Neurosci 1997; 9: 1422-1438.
3. Bethea JR et al. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 1998; 18: 3251-3260.
4. Bethea JR et al. Systemically administrated interleukin-10 reduces tumor necrosis factor-α production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 1999; 16: 851-863.
5. Hayashi M et al. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 2000; 17: 203-218.
6. Klusman I, Schwab ME. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res 1997; 762: 173-184.
7. Popovich PG et al. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 1997; 377: 443-464.
8. Schwab ME, Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 1996; 76: 319-370.
9. Schnell L et al. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci 1999a; 11: 3648-3658.
10. Schnell L et al. Cytokine-induced acute inflammation in the brain and spinal cord. J Neuropathol Exp Neurol 1999b; 55: 245-254.
11. Grimpe B, Silver J. The extracellular matrix in axon regeneration. Prog Brain Res 2002; 137: 333-349.
12. Jones LL, Tuszynski MH. Spinal cord injury expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. J Neurosci 2002; 22: 4611-4624.
13. Zhang Y et al. Tenascin-C expression and axonal sprouting following injury to the spinal dorsal columns in the adult rat. J Neurosci Res 1997; 49: 433-450.
14. Popovich PG. Immunonological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog Brain Res 2000; 128: 43-58.
15. Beattie MS, Bresnahan JC. Cell death, repair, and recovery of function after spinal cord injury in rats. In: Kalb RG, Strittmatter SM (eds). Neurobiology of Spinal Cord Injury. Humana Press Inc.: Totowa, NJ 2000.
16. Liu XZ et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neuosci 1997; 17: 5395-5306.
17. Marmarou A et al. Traumatic brain tissue acidosis: experimental and clinical studies. Acta Neurochir Suppl 1993; 57: 160-164.
18. Segal JL et al. Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries. Arch Phys Med Rehabil 1997; 78: 44-47.
19. Beattie MS et al. Cell death and plasticity after experimental spinal cord injury. Prog Brain Res 2000; 128: 9-21.
20. Basso DM et al. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transsection. Exp Neurol 1996; 139: 244-256.
21. Basso DM et al. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork reliability. J Neurotrauma 1996; 13: 343-359.
22. Constantini S, Young W. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J Neurosurg 1994; 80: 97-111.
23. Gruner JA. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma 1992; 9: 123-128.
24. Behrmann DL et al. Spinal cord injury produced by consistent mechanical displacement of the cord in rats: behavioral and histologic analysis. J Neurotrauma 1992; 9: 197-217.
25. Bresnahan JC. A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp Neurol 1987; 95: 548-570.
26. Casha S et al. Oligodendroglial apoptosis occurs along degenerating axons and is associated with Fas and p75 expression following spinal cord injury in the rat. Neuroscience 2001; 103: 203-218.
27. Abraham KE et al. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opiod mRNA expression and the onset of pain-related behaviour following excitotoxic spinal cord injury. Neuroscience 2001; 104: 836-874.
28. Plunkett J et al. Effects of interleukin-10 on pain behavior and gene expression following excititoxic spinal cord injury in the rat. Exp Neural 2001; 168: 144-154.
29. Beattie MS et al. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 2002; 36: 375-386.
30. Joshi M, Fehlings M. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcome, and histopathology. J Neurotrauma 2002; 19: 175-190.
31. Joshi M, Fehlings M. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationship between axonal tracts, residual tissue, and locomotor recovery. J Neurotrauma 2002; 19: 191-203.
32. Stokes BT, Jakeman LB. Experimental modeling of human spinal cord injury: a model that crosses the species barrier and mimics the spectrum of human cytopathology. Spinal Cord 2002; 40: 101-109.
33. Beal MF. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 2000; 23: 298-304.
34. Beattie MS et al. Cell death in models of spinal cord injury. Prog Brain Res 2002; 137: 37-47.
35. Davies SJ, Silver J. Adult axon regeneration in adult CNS white matter. Trends Neurosci 1998; 21: 515.
36. Hausmann ON et al. Spinal cord injury induces expression of RGS7 in microglia/macrophages in rats. Eur J Neurosci 2002; 15: 602-612.
37. Noble LJ et al. Disruption and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res 1989; 482: 57-66.
38. Pan W, Kastin AJ. Increase in TNFalpha transport after SCI is specific for time, region, and type of lesion. Exp Neurol 2001; 170: 357-363.
39. Mautes AE et al. Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther 2000; 80: 673-687.
40. Tator CH, Koyanagi I. Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 1997; 86: 483-492.
41. Saikumar P et al. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 1998; 17: 3341-3349.
42. Mills CD et al. Changes in metabotropic glutamate receptor expression following spinal cord injury. Exp Neurol 2001; 170: 244-257.
43. Ha BK et al. Kainate-induced excitotoxicity is dependent upon extracellular potassium concentrations that regulate the activity of AMPA/KA type receptors. J Neurochem 2002; 83: 934-945.
44. Mills CD et al. Involvement of metabotropic glutamate receptors in excitatory amino acid and GABA release following spinal cord injury in rat. J Neurochem 2001; 79: 835-848.
45. Chu GK et al. Calcium and neuronal death in spinal neurons. In: Kalb RG, Strittmatter SM (eds). Neurobiology of Spinal Cord Injury. Humana Press Inc.: Totowa, NJ 2000.
46. Regan RF, Choi DW. Glutamate neurotoxicity in spinal cord cell culture. Neuroscience 1991; 43: 585-591.
47. Vera-Portocarrero LP et al. Rapid changes in expression of glutamate transporters after spinal cord injury. Brain Res 2002; 927: 104-110.
48. Regan RF. The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons. Neurosci Lett 1996; 213: 9-12.
49. Choi DW. Glutamate receptors and the induction of excitotoxic neuronal cell death. Curr Opin Neurobiol 1996; 6: 667-672.
50. Jansco G et al. Neurotoxin induced nerve cell degeneration: possible involvement of calcium. Brain Res 1984; 295: 211-216.
51. Aizenman E et al. Oxygen free radicals regulate NMDA receptor function via a redox modulatory site. Neuron 1990; 5: 841-846.
52. Schmidley JW. Free radicals in the central nervous system ischemia. Stroke 1990; 21: 1086-1090.
53. Dalkara T et al. Constitutive nitric oxide synthase and ischemic/excitotoxic brain injury. In: Ruffolo RR et al (eds). Inflammatory Cells and Mediators in CNS Diseases. New Academic Publishers: Amsterdam 1999.
54. Lipton SA et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626-631.
55. Nakahara S et al. Changes in nitric oxide and expression of nitric oxide synthase in spinal cord after traumatic injury in rats. J Neurotrauma 2002; 11: 1467-1474.
56. Bao F, Liu D. Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience 2002; 115: 839-849.
57. Dawson VL et al. Mechanisms of nitric oxide-mediated neurotoxicity in primary cortical cultures. J Neurosci 1993; 13: 2651-2661.
58. Brewer GJ, Wallimann T. Protective effects of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem 2000; 74: 1968-1978.
59. Hausmann ON et al. Protective effects of oral creatine supplementation prior to spinal cord injury in rats. Spinal Cord 2002; 40: 449-456.
60. Taoka Y, Okajima K. Role of leucocytes in spinal cord injury in rats. J Neurotrauma 2000; 17: 219-229.
61. Carlson SL et al. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 1998; 151: 77-88.
62. Chatzipanteli K et al. Post-traumatic hypothermia reduces polymorphnuclear leucocyte accumulation following spinal cord injury in rats. J Neurotrauma 2000; 17: 321-332.
63. Taoka Y, Okajima K: Spinal cord injury in the rat. Prog Neurobiol 1998; 56: 341-358.
64. Watanabe T et al. Differential activation of microglia after experimental spinal cord injury. J Neurotrauma 1999; 16: 255-265.
65. Streit WJ et al. Functional plasticity of microglia: a review. Glia 1988; 1: 301-307.
66. Shuman SL et al. Apoptosis of microglia and oligodendrocytes after spinal cord injury in rats. J Neurosci Res 1997; 50: 798-808.
67. Schwartz M. Autoimmune involvement in CNS trauma is beneficial if well controlled. Prog Brain Res 2000; 128: 259-263.
68. Rapalino O et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 1998; 4: 814-821.
69. Hauben E et al. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 2000; 354: 286-287.
70. Nevo U et al. Diffusion anisotrophy MRI for quantitative assessment of recovery in injured rat spinal cord. Magn Reson Med 2001; 45: 1-9.
71. Stichel CC, Müller HW. The CNS lesion scar: new vistas on an old regeneration barrier. Cell Tissue Res 1998; 249: 1-9.
72. Fawcett JW. Spinal cord repair: from experimental models to human application. Spinal Cord 1998; 36: 811-817.
73. Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull 1999; 49: 377-391.
74. Fitch MT, Silver J, Glial cell extracellular matrix: boundaries for axon growth in the development and regeneration. Cell Tissue Res 1997a; 290: 379-384.
75. Goss JR. Astrocytes are the major source nerve growth factor upregulation following traumatic brain injury in the rat. Exp Neurol 1998; 149: 301-309.
76. Liesi P et al. Laminin is induced in astrocytes of the adult brain by injury. EMBO J 1984; 3: 683-686.
77. Davies SJ et al. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997; 390: 680-683.
78. Davies SJ et al. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999; 19: 5810-5822.
79. McGraw J et al. Modulating astrogliosis after neurotrauma. J Neurosci Res 2001; 63: 109-115.
80. Emery E et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg 1998; 89: 911-920.
81. Majno G et al. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146: 3-15.
82. Crowe MJ et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997; 3: 73-76.
83. Springer JE et al. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med 1999; 5: 943-946.
84. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17: 3261-3270.
85. Li GL et al. Changes of Fas and Fas ligand immunoreactivity after compression trauma to rat spinal cord. Acta Neuropathol 2000; 100: 75-81.
86. Zurita M et al. Presence and significance of CD-95 (Fas/APO1) expression after spinal cord injury. J Neurosurg (Spine) 2001; 94: 257-264.
87. Lee YB et al. Role of tumor necrosis factor-α in neuronal and glial apoptosis after spinal cord injury. Exp Neurol 2000; 166: 190-195.
88. Wada S. Apoptosis following spinal cord injury in rats and preventative effects of N-methyl-D-aspartate receptor agonist. J Neurosurg (Spine 1) 1999; 91: 98-104.
89. Rabchevsky AG et al. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. J Neurotrauma 1999; 16: 817-830.
90. Zurita M et al. Effects of dexamethasone on apoptosis-related cell death after spinal cord injury. J Neurosurg (Spine) 2002; 96: 83-89.
91. Wrathall JR et al. Myelin gene expression after experimental contusive spinal cord injury. J Neurosci 1998; 18: 8780-8793.
92. Purves D et al. Intracellular signal transduction. In: Purves D et al (eds). Neuroscience. 2nd ed. Sinauer Associates: Sunderland, MA 2001.
93. O'Farrell AM et al. IL-10 inhibits macrophage activation and proliferation by distinct signalling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J 1998; 17: 1006-1013.
94. Dietrich WD et al. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp Neurol 1999; 158: 444-450.
95. Knoblauch SM et al. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 1998; 153: 143-151.
96. Bruce AJ et al. Alterated neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996; 2: 788-794.
97. Holmin S et al. Intracerebral administration of interleukin-1b and induction of inflammation, apoptosis, and vasogenic edema. J Neurosurg 2000, 92: 108-120.
98. Streit WJ et al. Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration. J Neurosci Res 2000; 61: 10-20.
99. Lacroix S et al. Delivery of hyper-interleukin-6 to the injured signal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J Comp Neurol 2002; 454: 213-228.
100. Pan JZ et al. Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion. J Neurosci Res 2002; 68: 315-322.
101. Wang CX et al. Increase of interleukin-1B mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res 1997; 759: 190-196.
102. Anthony DC et al. Age-related effects of interleukin 1B on polymorphnuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997; 120: 435-444.
103. Benzing T et al. Upregulation of RGS7 may contribute to tumor necrosis factor induced changes in central nervous function. Nat Med 1999; 5: 913-918.
104. Bradburry EJ et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636-640.
105. Birkedal-Hansen H et al. Matrix metalloproteases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250.
106. Noble LJ et al. Matrix metalloproteases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 2002; 22: 7526-7535.
107. Xu J et al. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and metalloproteinase expression after spinal cord injury. J Neurosci 2001; 2: 502-511.
108. Guang C et al. Beneficial effects of modest hypothermia on locomotor function and histopathological damage following contusion-induced spinal cord injury in rats. J Neurosurg (Spine 1) 2000; 93: 85-93.
109. Stevens JD, Tetzlaff W. Strategies for spinal cord repair. In: Kalb RG, Strittmatter SM (eds). Neurobiology of Spinal Cord Injury, Humana Press Inc.: Totowa, NJ 2000.
110. Behrmann DL et al. Modeling spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone and YM-14673. Exp Neurol 1994; 126: 61-75.
111. Fitch MT, Silver J, Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increase in putative molecules. Exp Neurol 1997b; 148: 587-603.
112. Krautstrunk M et al. Increased expression of the putative axon growth-repulsive extracellular matrix molecule, keratan sulphate proteoglycan, following traumatic injury of the adult rat spinal cord. Acta Neuropathol 2002; 104: 592-600.
113. Schwartz M. Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines. Prog Neurobiol 2001; 65: 489-496.
114. Yakolev AG et al. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 1997; 17: 7415-7424.